Investigating the surface characteristics of nano delivery systems and their interactions with plasma is essential in determining the post-delivery fate of a drug product.

The National Cancer Institute’s (NCI) Nanotechnology Characterization Laboratory (NCL) conducts preclinical characterization, including physicochemical in vitro and in vivo analysis of nanoparticles, intended as cancer therapeutics and diagnostics.

Join our webinar featuring guest speaker Dr. Jeffrey D. Clogston, Principal Scientist, NCL to learn about:

  • The methodology and analytical techniques used to characterize nano delivery systems (including the testing of more than 425 nanotechnology-based candidate cancer treatments and diagnostics)
  • Characterization techniques such as dynamic and static light scattering, zeta potential, and asymmetric-flow field-flow fractionation (AF4)
  • How these techniques are used to assess the stability of nano delivery systems in plasma